Innovations in Genicular Outcomes Registry
ConditionKnee Osteoarthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPacira Pharmaceuticals, Inc
About this trial
The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).
Eligibility criteria
Qualifiers
Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator
Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application
Disqualifiers
Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol
Planning to have a surgery other than on the target knee
Trial design
Treatments tested in this trial
- Treatment for Knee OA
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov